Suchergebnisse - "Zambelli, Alberto"

PubPharm (6)

1

Randomized, open-label, phase II, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with locally advanced, inflammatory, or early HER2-positive breast cancer-Immun-HER trial (GOIRC-01-2016)

enthalten in: Journal for immunotherapy of cancer | 2023

von Pellegrino, B. | Tommasi, C. | Serra, O. | +21

2

Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes : sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolment

enthalten in: The British journal of surgery | 2023

von Tinterri, C. | Canavese, G. | Gatzemeier, W. | +61

CommentIn: Br J Surg. 2023 Nov 9;110(12):1903. - PMID 37815157

3

Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer

enthalten in: The New England journal of medicine | 2023

von Turner, N. | Oliveira, M. | Howell, S. | +121

4

Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer

enthalten in: The New England journal of medicine | 2022

von Cortés, J. | Kim, S. | Chung, W. | +122

CommentIn: Nat Rev Clin Oncol. 2022 May;19(5):283. - PMID 35361895

5

Everolimus plus aromatase inhibitors as maintenance therapy after first-line chemotherapy : Final results of the phase III randomised MAIN-A (MAINtenance Afinitor) trial

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Guarneri, V. | Giorgi, C. | Cinieri, S. | +23

6

A randomized multicenter study of optimal circadian time of vinorelbine combined with chronomodulated 5-fluorouracil in pretreated metastatic breast cancer patients : EORTC trial 05971

enthalten in: Chronobiology international | 2008

von Coudert, B. | Focan, C. | Genet, D. | +13

1
[1]